Update on KNDI and EXEL
Kandi Technolgies Group, Inc. (KNDI)
KNDI is up 26.6% today to $18.64. If you recall, I wrote on my blog to sale on bounce. I will take some profit and sit tight with the remaining portion of share for long term.
Why is the share up 20% today?
KNDI sold 4,114 Kandi brand Electric Vehicles during second quarter of 2014, a 238% increase from 1,215 EVs in the first quarter of 2014. Kandi expects to report its second quarter financial results on August 11, 2014.
KNDI sold 4,114 Kandi brand Electric Vehicles during second quarter of 2014, a 238% increase from 1,215 EVs in the first quarter of 2014. Kandi expects to report its second quarter financial results on August 11, 2014.
Exelixis, Inc. (EXEL)
The stock shot up today 23% after announcing positive top-line results from a phase 3 study involving the combination of cobimetinib and Zelboraf in patients with BRAF V600 mutation-positive advanced melanoma. According to the press release from Roche (partner of EXEL) discovered that the jointly developed drug has met the primary endpoint of a statistically significant increase in progression-free survival compared to patients who took Zelboraf alone. The full data from its study is expected later this year and if approved, Exelixis and Roche will help co-promote the drug. I would sell some to mitigate risk.
FYI, my next blog expected in next few days. Thanks!!
Comments
Post a Comment